AFT Pharmaceuticals Ltd (AFP)

Currency in AUD
2.45
0.00(0.00%)
Closed·
AFP Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
AFP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.442.45
52 wk Range
2.153.16
Key Statistics
Bid/Ask
2.42 / 2.45
Prev. Close
2.45
Open
2.44
Day's Range
2.44-2.45
52 wk Range
2.15-3.16
Volume
476
Average Volume (3m)
2.8K
1-Year Change
-13.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AFP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

AFT Pharmaceuticals Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

AFT Pharmaceuticals Ltd Company Profile

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, pain management, skin care, vitamins, and supplements, as well as other products. The company has collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Employees
119
Market
Australia

Compare AFP to Peers and Sector

Metrics to compare
AFP
Peers
Sector
Relationship
P/E Ratio
23.3x22.3x−0.5x
PEG Ratio
−0.92−0.030.00
Price/Book
2.9x2.0x2.6x
Price / LTM Sales
1.3x2.2x3.3x
Upside (Analyst Target)
-24.2%42.9%
Fair Value Upside
Unlock9.1%6.2%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.11%
Dividend Yield
0.68%
Industry Median 1.76%
Annualised payout
0.02
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 22, 2025
EPS / Forecast
0.14 / --
Revenue / Forecast
121.31M / --
EPS Revisions
Last 90 days

AFP Income Statement

FAQ

What Stock Exchange Does AFT Pharmaceuticals Trade On?

AFT Pharmaceuticals is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for AFT Pharmaceuticals?

The stock symbol for AFT Pharmaceuticals is "AFP."

What Is the AFT Pharmaceuticals Market Cap?

As of today, AFT Pharmaceuticals market cap is 256.92M.

What Is AFT Pharmaceuticals's Earnings Per Share (TTM)?

The AFT Pharmaceuticals EPS (TTM) is 0.11.

From a Technical Analysis Perspective, Is AFP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has AFT Pharmaceuticals Stock Split?

AFT Pharmaceuticals has split 0 times.

How Many Employees Does AFT Pharmaceuticals Have?

AFT Pharmaceuticals has 119 employees.

What is the current trading status of AFT Pharmaceuticals (AFP)?

As of 12 Aug 2025, AFT Pharmaceuticals (AFP) is trading at a price of 2.45, with a previous close of 2.45. The stock has fluctuated within a day range of 2.44 to 2.45, while its 52-week range spans from 2.15 to 3.16.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.